Marseilles
France
4
2020-03-12
4
2022-03-01
These are the the leading inventors for applications assigned to GENOSCIENCE PHARMA:
GENOSCIENCE PHARMA based in Marseilles, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases
#2 | 2019-10-17 ✅ Patent 10,722,505 granted on 2020-07-28Substituted 2,4 diamino-quinoline as new anticancer agents
#3 | 2019-05-16 ✅ Patent 10,577,362 granted on 2020-03-03Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases
#4 | 2016-09-29 ✅ Patent 10,179,770 granted on 2019-01-15Quinolines derivatives as novel anticancer agents
Also check out Genoscience Pharma's (Marseilles, France) applicant profile with 4 patent applications submitted.
373316 ⎘